PDS Biotechnology Corporation (NASDAQ: PDSB) – Not A Clear Buying Opportunity?
PDS Biotechnology Corporation (PDSB) concluded trading on Thursday at a closing price of $1.57, with 0.54 million shares of worth about $0.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.50% during that period and on May 22, 2025 the price saw a […]
